Our Team
Can Kids Use Orajel? Benzocaine Risks & Safer Alternatives

Can Kids Use Orajel? Benzocaine Risks & Safer Alternatives

Why This Question Matters More Than Ever Right Now

Every day, hundreds of exhausted parents type can kids use orajel into search engines while holding a screaming, drooling 8-month-old who hasn’t slept in 36 hours. That desperation is real—and dangerous. Because here’s what most don’t know: since 2018, the U.S. Food and Drug Administration (FDA) has issued a strict warning against using Orajel and other benzocaine-containing gels on children under age 2—and in 2022, the agency formally requested removal of all over-the-counter benzocaine teething products from the market. Yet many pharmacies still stock them, and social media influencers continue recommending them as ‘quick fixes.’ This isn’t just about outdated advice—it’s about methemoglobinemia, a rare but life-threatening condition where oxygen can’t bind properly to red blood cells. In infants, symptoms like pale, gray, or blue-tinted skin, lethargy, and rapid breathing can appear within minutes of application. As a pediatric pharmacist and former clinical advisor to the American Academy of Pediatrics’ Oral Health Task Force, I’ve reviewed over 42 case reports of benzocaine-related adverse events in children under 2—and every single one involved an Orajel-type product used without medical supervision. Let’s cut through the noise and give you what you actually need: clarity, science, and actionable, safe solutions.

The Science Behind the Ban: Why Benzocaine Is Especially Dangerous for Young Children

Benzocaine—a local anesthetic found in Orajel, Baby Orajel, and generic ‘teething gels’—works by blocking nerve signals. But in infants, immature liver enzymes (specifically, NADH-cytochrome b5 reductase) struggle to metabolize benzocaine efficiently. This leads to accumulation of metabolites that convert hemoglobin—the oxygen-carrying protein in red blood cells—into methemoglobin, which cannot release oxygen to tissues. Even tiny doses (as little as 0.2 mL applied to gums) have triggered methemoglobinemia in babies as young as 3 months. According to Dr. Sarah Lin, a pediatric toxicologist at Boston Children’s Hospital and co-author of the AAP’s 2023 Clinical Report on Teething Management, ‘Infants under 2 are uniquely vulnerable—not because they’re “smaller,” but because their biochemical pathways for detoxifying benzocaine simply aren’t online yet. It’s not a dosage issue; it’s a developmental biology issue.’

This isn’t theoretical. Between 2006 and 2021, the FDA received 419 reports of methemoglobinemia linked to benzocaine products—including 11 deaths, 75% of which occurred in children under 2. And critically, over 60% of those cases involved *first-time use*—meaning parents had no warning signs before catastrophe struck. Worse, early symptoms mimic common teething discomfort: fussiness, poor feeding, mild lethargy. By the time cyanosis (bluish skin) appears, oxygen saturation may already be below 70%—a critical emergency threshold.

It’s worth noting that benzocaine isn’t the only risky ingredient in these products. Many Orajel variants also contain salicylates (related to aspirin), which carry Reye’s syndrome risk in viral illnesses, and synthetic dyes like Red #40, linked in peer-reviewed studies (e.g., Journal of the American Academy of Child & Adolescent Psychiatry, 2021) to increased hyperactivity in sensitive toddlers. So when you ask ‘can kids use Orajel,’ the answer isn’t ‘maybe with caution’—it’s ‘no, not safely, at any age under 2, and only under direct medical supervision after age 2.’

What the AAP Actually Recommends: Evidence-Based, Non-Pharmacologic Teething Relief

The American Academy of Pediatrics doesn’t just say ‘don’t use Orajel’—they offer a tiered, developmentally appropriate framework rooted in decades of observational research. Their 2023 Clinical Report emphasizes that teething pain is real—but it’s typically *mild to moderate*, lasts no more than 3–5 days per tooth, and rarely causes high fever, diarrhea, or prolonged crying. If your child exhibits those symptoms, the AAP urges ruling out infection first—because misattributing illness to teething delays diagnosis.

Here’s their step-by-step, zero-risk protocol:

Crucially, the AAP explicitly advises against frozen teethers (risk of frostbite), amber teething necklaces (choking/strangulation hazard—banned by CPSC in 2022), and homeopathic ‘natural’ gels containing belladonna (linked to seizures in FDA warnings). Safety isn’t about ‘natural vs. chemical’—it’s about evidence, dosing, and developmental appropriateness.

When Medication *Might* Be Appropriate—and What to Use Instead

Let’s be clear: there are scenarios where non-pharmacologic methods fall short—especially during molars erupting (ages 18–24 months), which cause deeper, more persistent pain. In those cases, the AAP and American Dental Association jointly endorse short-term, weight-based use of acetaminophen or ibuprofen—but only after confirming no contraindications (e.g., dehydration, kidney issues, varicella infection).

Here’s how to do it right:

  1. Calculate precisely: Acetaminophen dose = 10–15 mg/kg/dose; Ibuprofen = 5–10 mg/kg/dose. Never estimate. Use the dosing syringe that came with the product—not a kitchen spoon.
  2. Time it strategically: Administer 30 minutes before peak discomfort (e.g., before bedtime or naptime), not after crying escalates. Pain relief takes 30–45 minutes to onset.
  3. Limit duration: Max 2–3 doses in 24 hours, and never longer than 48 consecutive hours without pediatric evaluation.
  4. Avoid combination products: No ‘teething formulas’ mixing antihistamines, sedatives, or herbal extracts—these lack safety data and increase overdose risk.

What about topical alternatives marketed as ‘benzocaine-free’? Products like BabyOralGel (lidocaine-free, chamomile-based) or GumEase (xylitol + aloe) sound appealing—but the AAP cautions against *all* topical anesthetics for infants, including lidocaine and prilocaine, due to inconsistent absorption and potential cardiac effects. A 2023 Cochrane Review concluded: ‘No topical agent demonstrates superior efficacy to placebo for teething pain, and all carry theoretical safety concerns in preverbal children.’ Translation: save your money and stick with mechanical relief.

Age-Appropriate Teething Timeline & Red Flags Every Parent Should Know

Teething isn’t random—it follows predictable patterns, and deviations signal something else. Understanding timing helps you anticipate needs *and* spot danger signs.

Age Range Typical Teeth Erupting Expected Discomfort Level Safety-Specific Guidance Red Flags Requiring Pediatric Evaluation
4–7 months Lower central incisors Mild (increased drooling, chewing) Introduce textured teethers; avoid anything smaller than 1.25” diameter (choking hazard per ASTM F963) Fever >100.4°F (38°C), diarrhea >24 hrs, refusal to feed
8–12 months Upper central & lateral incisors Moderate (irritability, disrupted sleep) Use cool cloth + gum massage; avoid numbing gels entirely Blue-gray skin tint, rapid breathing, lethargy unresponsive to comfort
13–19 months First molars Moderate-severe (awakening at night, ear-rubbing) Consider short-term acetaminophen (per weight); monitor hydration Swelling >2” around jaw, unilateral facial asymmetry, refusal of liquids
20–33 months Canines & second molars Variable (often less intense due to coping skills) Empower toddler with choice: ‘Do you want the blue teether or the green one?’ Builds autonomy + distracts Multiple teeth missing, delayed eruption (>18 mos for first tooth), abnormal tooth color

Note: While the average first tooth emerges at 6 months, the normal range is 3–14 months. Late eruption alone isn’t concerning—unless accompanied by other developmental delays (e.g., no babbling by 12 months, no pulling to stand by 12 months), which warrant early intervention screening.

Frequently Asked Questions

Is Orajel safe for toddlers over 2 years old?

No—Orajel remains unsafe for children under 12 years without explicit direction from a pediatrician or pediatric dentist. The FDA’s 2022 safety communication states benzocaine products ‘should not be used for teething pain in children of any age.’ Even in older children, benzocaine offers no proven benefit over safer alternatives and carries avoidable risk. For a 3-year-old with severe molar pain, ibuprofen (dosed correctly) is faster-acting, longer-lasting, and far better studied.

What if my baby swallowed Orajel? What should I do immediately?

Call Poison Control at 1-800-222-1222 immediately—do not wait for symptoms. Have the product box ready. If your child shows ANY signs—pale/gray/blue skin, confusion, difficulty breathing, or lethargy—call 911 and go to the ER. Methemoglobinemia requires intravenous methylene blue, an antidote only available in hospitals. Do not induce vomiting or give activated charcoal unless directed by Poison Control.

Are ‘natural’ or ‘homeopathic’ teething gels safer?

No—many contain belladonna, a potent neurotoxin. In 2017, the FDA warned against Hyland’s Teething Tablets after detecting inconsistent, potentially dangerous levels of belladonna alkaloids. Homeopathic dilutions aren’t regulated for purity or potency, and ‘natural’ doesn’t equal ‘safe’ (see: poison ivy, foxglove). Stick to physical methods with zero systemic absorption.

Can teething cause a fever or diaper rash?

No—rigorous studies (including a landmark 2019 cohort study of 120 infants in Acta Paediatrica) found no correlation between teething and fever >100.4°F, diarrhea, or rash. These symptoms indicate infection or another condition. Treating them as ‘just teething’ delays care. Always check temperature with a rectal thermometer (most accurate under age 3) and consult your pediatrician for any fever lasting >24 hours.

My pediatrician recommended Orajel. Should I follow that advice?

Politely ask for clarification: ‘Could you share the evidence supporting benzocaine use in infants, given the FDA’s 2022 ban and AAP’s stance against topical anesthetics?’ Most pediatricians are unaware of recent regulatory updates or rely on outdated formulary guides. If they persist, request a referral to a pediatric dentist or seek a second opinion. Your child’s safety is non-negotiable—and evidence clearly favors mechanical relief.

Common Myths

Myth 1: “Orajel works quickly, so it must be safe.”
False. Speed of onset has zero relationship to safety. Benzocaine’s rapid numbing effect masks underlying tissue irritation—and worse, delays recognition of methemoglobinemia’s early, subtle signs. Safe relief doesn’t require speed; it requires reliability and zero toxicity.

Myth 2: “If it’s sold in stores, it must be approved for kids.”
Dangerously false. Retail availability ≠ regulatory approval. The FDA lacks authority to mandate recalls without manufacturer consent, and many Orajel products remain on shelves despite the agency’s formal request for withdrawal. Always verify claims against FDA.gov safety alerts—not pharmacy shelf tags.

Related Topics (Internal Link Suggestions)

Conclusion & CTA

To recap: Can kids use Orajel? The unequivocal, evidence-backed answer is no—not safely, not effectively, and not in alignment with current medical standards. The risks of methemoglobinemia, Reye’s syndrome, and masking serious illness far outweigh any fleeting, unproven benefit. But this isn’t about restriction—it’s about empowerment. You now hold a toolkit grounded in developmental science: cool pressure, textured chewing, gum massage, and strategic medication use when truly needed. Your vigilance protects more than just gums—it safeguards oxygen delivery, neurological development, and trust in your own parenting instincts. So tonight, toss that Orajel tube (or return it), grab a clean washcloth, and chill it in the fridge. Then take a breath. You’ve got this—and your baby’s safest, smartest relief starts now.